Search alternatives:
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 wt » 2 wt (Expand Search), 1 wt (Expand Search)
nm decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
12 wt » 2 wt (Expand Search), 1 wt (Expand Search)
-
101401
-
101402
-
101403
Table_2_Lung Inflation With Hydrogen During the Cold Ischemia Phase Alleviates Lung Ischemia-Reperfusion Injury by Inhibiting Pyroptosis in Rats.DOC
Published 2021“…</p><p>Results: Compared with the control group, the O<sub>2</sub> and H<sub>2</sub> groups improved oxygenation indices, decreases the inflammatory response and oxidative stress, reduced lung injury, and improved pressure-volume (P-V) curves. …”
-
101404
-
101405
-
101406
-
101407
-
101408
Understanding and Improving the Kinetics of Bulk Carbonation on Sodium Carbonate
Published 2020“…We find that the kinetics of Na<sub>2</sub>CO<sub>3</sub> bulk carbonation is controlled by the <i>I</i><sub>H</sub><sup>+</sup>/<i>V</i><sub>Na</sub><sup>–</sup> defect pair generation in Na<sub>2</sub>CO<sub>3</sub>; we predict that the kinetics can be enhanced by doping lithium into Na<sub>2</sub>CO<sub>3</sub>, which decreases the defect formation energy by 0.13 eV. …”
-
101409
Understanding and Improving the Kinetics of Bulk Carbonation on Sodium Carbonate
Published 2020“…We find that the kinetics of Na<sub>2</sub>CO<sub>3</sub> bulk carbonation is controlled by the <i>I</i><sub>H</sub><sup>+</sup>/<i>V</i><sub>Na</sub><sup>–</sup> defect pair generation in Na<sub>2</sub>CO<sub>3</sub>; we predict that the kinetics can be enhanced by doping lithium into Na<sub>2</sub>CO<sub>3</sub>, which decreases the defect formation energy by 0.13 eV. …”
-
101410
Understanding and Improving the Kinetics of Bulk Carbonation on Sodium Carbonate
Published 2020“…We find that the kinetics of Na<sub>2</sub>CO<sub>3</sub> bulk carbonation is controlled by the <i>I</i><sub>H</sub><sup>+</sup>/<i>V</i><sub>Na</sub><sup>–</sup> defect pair generation in Na<sub>2</sub>CO<sub>3</sub>; we predict that the kinetics can be enhanced by doping lithium into Na<sub>2</sub>CO<sub>3</sub>, which decreases the defect formation energy by 0.13 eV. …”
-
101411
Understanding and Improving the Kinetics of Bulk Carbonation on Sodium Carbonate
Published 2020“…We find that the kinetics of Na<sub>2</sub>CO<sub>3</sub> bulk carbonation is controlled by the <i>I</i><sub>H</sub><sup>+</sup>/<i>V</i><sub>Na</sub><sup>–</sup> defect pair generation in Na<sub>2</sub>CO<sub>3</sub>; we predict that the kinetics can be enhanced by doping lithium into Na<sub>2</sub>CO<sub>3</sub>, which decreases the defect formation energy by 0.13 eV. …”
-
101412
Understanding and Improving the Kinetics of Bulk Carbonation on Sodium Carbonate
Published 2020“…We find that the kinetics of Na<sub>2</sub>CO<sub>3</sub> bulk carbonation is controlled by the <i>I</i><sub>H</sub><sup>+</sup>/<i>V</i><sub>Na</sub><sup>–</sup> defect pair generation in Na<sub>2</sub>CO<sub>3</sub>; we predict that the kinetics can be enhanced by doping lithium into Na<sub>2</sub>CO<sub>3</sub>, which decreases the defect formation energy by 0.13 eV. …”
-
101413
Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease
Published 2017“…MiR-503 expression was decreased in COPD lung fibroblasts. The expression of miR-503 was positively correlated with %FVC, þV1, and %DLco as well as IL-6, -8, PGE<sub>2</sub>, HGF, KGF, and VEGF in the absence or presence of IL-1ß/TNF-α. …”
-
101414
-
101415
-
101416
The basic flowchart of analysis in this study.
Published 2025“…Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.</p><p>Conclusion</p><p>This study examined changes in intercellular communication between immune cells in the peripheral blood and identified five novel feature genes associated with cuproptosis in AD patients. …”
-
101417
The enriched GO terms of the 19 DECAGs.
Published 2025“…Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.</p><p>Conclusion</p><p>This study examined changes in intercellular communication between immune cells in the peripheral blood and identified five novel feature genes associated with cuproptosis in AD patients. …”
-
101418
Adenoviral vector mediated ferritin over-expression in mesenchymal stem cells detected by 7T MRI in vitro
Published 2017“…</p><p>Conclusions</p><p>Our study confirms that ferritin could be over-expressed in BMSCs as a result of rAdV mediated infection and could be quantitatively detected by 7T MRI device. …”
-
101419
Primers of the tested genes.
Published 2025“…Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.</p><p>Conclusion</p><p>This study examined changes in intercellular communication between immune cells in the peripheral blood and identified five novel feature genes associated with cuproptosis in AD patients. …”
-
101420
Summary of patient demographic characteristics.
Published 2025“…Finally, we discovered that the levels of <i>PDK1</i> expression in AD patients were remarkably upregulated, while <i>FDX1</i> and <i>GLS</i> were significantly decreased using qPCR.</p><p>Conclusion</p><p>This study examined changes in intercellular communication between immune cells in the peripheral blood and identified five novel feature genes associated with cuproptosis in AD patients. …”